Fundraising Fox
Fortress Biotech
NASDAQ: FBIONew York, US · Delaware corporation · 1 known investors
Find your way into Fortress Biotech
Each arrow is one introduction. Sign up to fill in the first one.
Ask Nihar Vete to introduce you to Lucy Lu
You →Nihar · together at Fortress Biotech →Lucy
Ask Jamie Chen to introduce you to Lindsay A. Rosenwald
You →Jamie · together at Fortress Biotech →Lindsay
Sign up to find every way you can get introduced to Fortress Biotech
- Your email: who you already know at Fortress Biotech, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Fortress Biotech team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Fortress Biotech is a biopharmaceutical company that acquires and advances assets across therapeutic areas including oncology, dermatology, and rare diseases, generating value through product revenue, equity holdings, and dividend and royalty income. The company operates a portfolio of marketed prescription pharmaceutical products and development programs through majority-owned subsidiaries and minority ownership positions in partner companies.
Founders & leadership
Board
Investors · 1
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$9.8M disclosed across 2 of 6 rounds · 1900–2026
▶$6.5MraisedMar 2018 · 2 investors · BiotechnologyRule 506(b)
- J. Jay LobellDirector
- George AvgerinosExecutive Officer
- Dov KleinDirector
- Malcolm HoenleinDirector
- Jimmie Harvey, Jr.Director
- Eric K. RowinskyDirector
- Michael WeissExecutive Officer, Director
- Robyn HunterExecutive Officer
- Lindsay A. RosenwaldExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $6.5M
- Sales commissions
- $521.4K
- Placement agents
- National Securities Corporation
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.3MraisedApr 2017 · 2 investors · BiotechnologyRule 506(b)
- Eric K. RowinskyDirector
- Lindsay A. RosenwaldExecutive Officer, Director
- Michael S. WeissDirector
- Dov KleinDirector
- Jimmie Harvey, Jr.Director
- Malcolm HoenleinDirector
- J. Jay LobellDirector
- George AvgerinosExecutive Officer
- Lucy LuExecutive Officer
- Amount sold
- $3.3M
- Sales commissions
- $325.4K
- Placement agents
- National Securities Corporation
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Related companies · 3
Companies working in the same space as Fortress Biotech.
In the news
Frequently asked questions
- What does Fortress Biotech do?
- Fortress Biotech is a biopharmaceutical company that acquires and advances assets across therapeutic areas including oncology, dermatology, and rare diseases, generating value through product revenue, equity holdings, and dividend and royalty income. The company operates a portfolio of marketed prescription pharmaceutical products and development programs through majority-owned subsidiaries and minority ownership positions in partner companies.
- Who are Fortress Biotech's investors?
- Fortress Biotech's investors include Frazier Life Sciences.
- How much funding has Fortress Biotech raised?
- Fortress Biotech has disclosed $9.8M raised across 2 of its 6 known rounds.
- Where is Fortress Biotech headquartered?
- Fortress Biotech is headquartered in New York, US.